Pantoprazole in Cisplatin Nephrotoxicity
ConditionOncology
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSherief Abd-Elsalam
About this trial
Pantoprazole in Cisplatin Nephrotoxicity
Eligibility criteria
Qualifiers
Patients with head and neck cancer
Disqualifiers
GFR less than 59.
DM
Elevated liver enzymes more than 3 fold.
Trial design
Treatments tested in this trial
- Pantoprazole low dose
- Pantoprazole high dose
- Standard hydration
- Cisplatin
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov